Ua hoʻāla ka poʻe loea i nā hopohopo e hiki ke hoʻohui i nā mea hoʻolako lāʻau lapaʻau i nā vial booster Omicron me nā hue i hoʻohana ʻia no nā kano maʻamau.
Ua puka mai kēlā mau hopohopo i ka pule i hala ma kahi hālāwai lehulehu o nā ʻōlelo aʻoaʻo CDC a ua hoʻopiʻi ʻia i ka Pōʻaono e kahi papa o nā loea olakino ma ʻehā mau mokuʻāina, me Kaleponi, e like me ka Western States Scientific Security Review Task Force.
"Ma muli o ke ʻano o ka hoʻohālikelike ʻana no nā pūʻulu makahiki like ʻole, ke hopohopo nei ka hana hana i hiki mai nā hewa i ka lawe ʻana i nā kano COVID-19 ʻē aʻe," i ʻōlelo ai ka hui ma kahi ʻōlelo. "Pono ʻo COVID-19 e kahele ʻia i ka heluna kanaka." . nā mea hoʻolako lāʻau lapaʻau āpau.-19 Nā alakaʻi alakaʻi.
Ua kapa ʻia ka lāʻau lapaʻau hou he bivalent. Hoʻolālā ʻia lākou e pale aku ʻaʻole wale i ka maʻi coronavirus kumu, akā no ka BA.5 a me kekahi sub-variant Omicron i kapa ʻia ʻo BA.4. Ua laikini wale ʻia nā mea hoʻoikaika hou i nā poʻe ma mua o 12 mau makahiki.
ʻO nā pana kuʻuna he mau lāʻau lapaʻau monovalent i hoʻolālā ʻia e pale wale i ke kumu coronavirus kumu.
Pili ka huikau me ke kala o ka pāpale omole. ʻO kekahi mau nila hoʻoulu hou he mau pāpale like ke kala me nā nila kahiko.
No ka laʻana, hoʻokomo ʻia nā ʻinikini bivalent Pfizer maʻamau a me nā mea hou aku no ka poʻe he 12 makahiki a ʻoi aku i loko o kahi pāpale omole i like ke kala-hina, e like me nā kiʻi paheʻe mai kahi hōʻike CDC i nā ʻōlelo aʻoaʻo ʻepekema i ka pule i hala. Pono nā kauka lapaʻau e heluhelu i nā lepili e hoʻokaʻawale i nā kano maʻamau mai nā mea hoʻoikaika hou.
Loaʻa i nā hue ʻelua ka nui o ka lāʻau lapaʻau - 30 micrograms - akā ua hoʻomohala ʻia ka lāʻau kuʻuna e kūʻē i ka maʻi coronavirus kumu, aʻo ka lāʻau lapaʻau hou i hoʻokaʻawale i ka hapalua no ke kumu kumu a me ke koena no ka subvariant BA.4/BA.5 Omicron. .
Hoʻopili hou ʻia ka lepili Pfizer booster e hoʻokomo i ka "Bivalent" a me "Original & Omicron BA.4/BA.5″.
ʻO kahi kumu o ka huikau me ka lāʻau lapaʻau Moderna, ʻo ia ka poʻe ʻōmole no ka lāʻau lapaʻau mua maʻamau no nā keiki mai 6 a hiki i 11 makahiki a ʻo ka lāʻau lapaʻau hou no nā pākeke he uliuli ʻeleʻele.
Loaʻa i nā hue ʻelua i ka nui like o ke kano - 50 mcg. Akā ʻo nā kumu mua āpau o ka mana o nā keiki e helu ʻia ma ke kumu kumu o ka coronavirus. ʻO ka hapalua o ka hoʻoulu hou ʻana o nā mākua no ke kānana kumu a ʻo ke koena no ka sub-variant BA.4/BA.5.
ʻO ka lepili o ka mea hoʻonui Omicron hou i ʻōlelo ʻia "Bivalent" a me "Original a me Omicron BA.4/BA.5″.
Pono nā mea hoʻolako lāʻau lapaʻau e mālama pono i ka hāʻawi ʻana i ke kano kūpono i ke kanaka kūpono.
Ma kahi puʻupuʻu paʻi ma ka Pōʻalua, ua ʻōlelo ʻo White House COVID-19 Response Coordinator Dr. Ashish Jha e hana ana nā ʻepekema FDA e hōʻoia i ka hoʻomaʻamaʻa pono ʻana o nā mea hoʻolako i nā limahana no laila "hiki i nā poʻe ke loaʻa i ke kano kūpono."
"ʻAʻole mākou i ʻike i kahi hōʻike i loaʻa ka hewa nui a i ʻole ke loaʻa ʻana o ka poʻe i ka maʻi kano hewa. Manaʻo wau e hoʻomau ka ʻōnaehana i ka hana maikaʻi, akā ʻike wau e hoʻomau ka FDA e nānā pono i kēia. " wahi a Jah.
Ua ʻōlelo ka luna o CDC, ʻo Dr. Rochelle Walensky, ke hana ikaika nei kāna ʻoihana e kahele i nā kiʻi pāpale a aʻo i nā luna hoʻomalu "e hōʻemi i ka huikau."
ʻO Rong-Gong Lin II kahi mea hoʻolaha Metro i hoʻokumu ʻia ma Kapalakiko e loea i ka palekana o ke olai a me ka maʻi maʻi maʻi COVID-19. Ua puka ʻo ka Bay Area mai UC Berkeley a hui pū me ka Los Angeles Times ma 2004.
ʻO Luc Money kahi mea hoʻolaha Metro e uhi ana i ka nūhou no ka Los Angeles Times. Ma mua, ʻo ia ka mea hoʻolaha a me ke kōkua hoʻoponopono kūlanakauhale no ka Orange County Times Daily Pilot, kahi nūhou lehulehu, a ma mua o ia mea ua kākau ʻo ia no ka Santa Clarita Valley Signal. Loaʻa iā ia ke kēkelē laepua ma ka nūpepa mai ke Kulanui o Arizona.
Ka manawa hoʻouna: Jan-29-2023